As the product stewardship movement gains steam, attention is turning to the issue of unsafe disposal of residue or unwanted consumer pharmaceuticals. The widespread detection of pharmaceutical residues in public waters and fish has raised biologists’ concerns. In Minnesota, the popularity of public-sponsored take-back days and a coming legislative proposal in the 2010 session to create a network of collection facilities, funded by pharmaceutical makers, adds a new twist to the problem.